84 related articles for article (PubMed ID: 16700527)
1. The role of CD26/DPP IV in preservation of early pulmonary graft function.
Jung FJ; Cardell M; Yang L; De Meester I; Augustyns K; Hillinger S; Scharpe S; Weder W; Korom S
Adv Exp Med Biol; 2006; 575():231-5. PubMed ID: 16700527
[No Abstract] [Full Text] [Related]
2. CD26/DPP IV in experimental and clinical organ transplantation.
Korom S; de Meester I; Belyaev A; Schmidbauer G; Schwemmle K
Adv Exp Med Biol; 2003; 524():133-43. PubMed ID: 12675233
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation.
Biton A; Bank U; Täger M; Ansorge S; Reinhold D; Lendeckel U; Brocke S
Adv Exp Med Biol; 2006; 575():177-86. PubMed ID: 16700521
[No Abstract] [Full Text] [Related]
4. CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation.
Jungraithmayr W; De Meester I; Matheeussen V; Baerts L; Arni S; Weder W
Eur J Cardiothorac Surg; 2012 May; 41(5):1166-73. PubMed ID: 22219460
[TBL] [Abstract][Full Text] [Related]
5. Favorable effect of CD26/DPP-4 inhibitors on postoperative outcomes after lung transplantation: A propensity-weighted analysis.
Yamada Y; Sato T; Oda H; Harada N; Yoshizawa A; Nishikawa S; Kayawake H; Tanaka S; Yutaka Y; Hamaji M; Nakajima D; Ohsumi A; Date H
J Heart Lung Transplant; 2024 Jan; 43(1):66-76. PubMed ID: 37634575
[TBL] [Abstract][Full Text] [Related]
6. Role of neuropeptide Y and dipeptidyl peptidase IV in regulation of Ewing's sarcoma growth.
Kitlinska J; Kuo L; Abe K; Pons J; Yu M; Li L; Tilan J; Toretsky J; Zukowska Z
Adv Exp Med Biol; 2006; 575():223-9. PubMed ID: 16700526
[No Abstract] [Full Text] [Related]
7. Molecular recognition of ligands in dipeptidyl peptidase IV.
Kuhn B; Hennig M; Mattei P
Curr Top Med Chem; 2007; 7(6):609-19. PubMed ID: 17352681
[TBL] [Abstract][Full Text] [Related]
8. Possible role of DP IV inhibitors in acne therapy.
Thielitz A; Reinhold D; Vetter R; Lendeckel U; Kähne T; Bank U; Helmuth M; Neubert K; Faust J; Hartig R; Wrenger S; Zouboulis CC; Ansorge S; Gollnick H
Adv Exp Med Biol; 2006; 575():163-7. PubMed ID: 16700519
[No Abstract] [Full Text] [Related]
9. Specific inhibition of CD26/DPP IV enzymatic activity in allograft recipients: effects on humoral immunity.
Korom S; De Meester I; Schmidbauer G; Pratschke J; Brendel MD; Durinx C; Schwemmle K; Haemers A; Scharpé S; Kupiec-Weglinski JW
Transplant Proc; 1999; 31(1-2):778. PubMed ID: 10083329
[No Abstract] [Full Text] [Related]
10. Dipeptidyl peptidase 8 has post-proline dipeptidyl aminopeptidase and prolyl endopeptidase activities.
Park J; Ajami K; Yu DM; Gorrell MD
Adv Exp Med Biol; 2006; 575():93-102. PubMed ID: 16700512
[No Abstract] [Full Text] [Related]
11. Dipeptidyl peptidase IV: a molecular switch of vascular actions of neuropeptide Y.
Li L; Demuth HU; Zukowska Z
Adv Exp Med Biol; 2006; 575():135-40. PubMed ID: 16700516
[No Abstract] [Full Text] [Related]
12. Phosphorus-containing inhibitors of proteolytic enzymes.
Stöckel-Maschek A; Stiebitz B; Senns B; Lindner N; Mögelin W; Neubert K
Adv Exp Med Biol; 2006; 575():19-26. PubMed ID: 16700504
[No Abstract] [Full Text] [Related]
13. Is CD26/dipeptidyl peptidase IV a really important molecule in T cell activation of a certain rat strain?
Iwaki-Egawa S; Watanabe Y; Fujimoto Y
Immunobiology; 1995 Nov; 194(4-5):429-42. PubMed ID: 8749235
[TBL] [Abstract][Full Text] [Related]
14. CD26/dipeptidyl peptidase IV: a comparative study of healthy persons and kidney transplant recipients before and early after transplantation.
Leicht S; Shipkova M; Klett C; Gert H; Altrock E; Wilhelm J; Bolley R; Wollmeyer J; Ender A; Luz B; Olbricht C; Wieland E
Clin Biochem; 2013 Oct; 46(15):1383-8. PubMed ID: 23608353
[TBL] [Abstract][Full Text] [Related]
15. Relative contribution of incretins to the glucose lowering effect of DP IV inhibitors in type 2 diabetes mellitus (T2DM).
Hinke SA; Pederson RA; McIntosh CH
Adv Exp Med Biol; 2006; 575():119-33. PubMed ID: 16700515
[No Abstract] [Full Text] [Related]
16. Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else?
Juillerat-Jeanneret L
J Med Chem; 2014 Mar; 57(6):2197-212. PubMed ID: 24099035
[TBL] [Abstract][Full Text] [Related]
17. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.
Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A
Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068
[TBL] [Abstract][Full Text] [Related]
18. Neuroimmunomodulative properties of dipeptidyl peptidase IV/CD26 in a TNBS-induced model of colitis in mice.
Baticic L; Detel D; Kucic N; Buljevic S; Pugel EP; Varljen J
J Cell Biochem; 2011 Nov; 112(11):3322-33. PubMed ID: 21751235
[TBL] [Abstract][Full Text] [Related]
19. CD26/DPP IV-mediated modulation of acute rejection.
Korom S; De Meester I; Coito AJ; Graser E; Pratschke J; König S; Grimm H; Volk HD; Scharpé S; Kupiec-Weglinski JW
Transplant Proc; 1999; 31(1-2):873. PubMed ID: 10083382
[No Abstract] [Full Text] [Related]
20. The significance of hypersialylation of dipeptidyl peptidase IV (CD26) in the inhibition of its activity by Tat and other cationic peptides. CD26: a subverted adhesion molecule for HIV peptide binding.
Smith RE; Talhouk JW; Brown EE; Edgar SE
AIDS Res Hum Retroviruses; 1998 Jul; 14(10):851-68. PubMed ID: 9671214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
